The molecular and cellular basis of copper dysregulation and its relationship with human pathologies MT Maung, A Carlson, M Olea‐Flores, L Elkhadragy, ... The FASEB Journal 35 (9), e21810, 2021 | 71 | 2021 |
ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells K Bian, NR Muppani, L Elkhadragy, W Wang, C Zhang, T Chen, S Jung, ... Oncotarget 7 (6), 6665, 2016 | 47 | 2016 |
A regulatory BMI 1/let‐7i/ERK 3 pathway controls the motility of head and neck cancer cells L Elkhadragy, M Chen, K Miller, MH Yang, W Long Molecular oncology 11 (2), 194-207, 2017 | 40 | 2017 |
Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness L Elkhadragy, H Alsaran, M Morel, W Long Journal of Biological Chemistry 293 (42), 16193-16205, 2018 | 32 | 2018 |
Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation RC Gaba, L Elkhadragy, FE Boas, S Chaki, HH Chen, M El-Kebir, ... Oncotarget 11 (28), 2686, 2020 | 23 | 2020 |
The C-terminus tail regulates ERK3 kinase activity and its ability in promoting cancer cell migration and invasion L Elkhadragy, H Alsaran, W Long International journal of molecular sciences 21 (11), 4044, 2020 | 19 | 2020 |
L290P/V mutations increase ERK3’s cytoplasmic localization and migration/invasion-promoting capability in cancer cells H Alsaran, L Elkhadragy, A Shakya, W Long Scientific reports 7 (1), 14979, 2017 | 16 | 2017 |
A repertoire of microRNAs regulates cancer cell starvation by targeting phospholipase D in a feedback loop that operates maximally in cancer cells K Fite, L Elkhadragy, J Gomez-Cambronero Molecular and cellular biology 36 (7), 1078-1089, 2016 | 16 | 2016 |
Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 … RC Gaba, RC Khabbaz, RN Muchiri, JD Morrison, L Elkhadragy, ... Drug Delivery and Translational Research, 1-13, 2021 | 8 | 2021 |
Generation of genetically tailored porcine liver cancer cells by CRISPR/Cas9 editing L Elkhadragy, MR Regan, W M Totura, KD Goli, S Patel, K Garcia, ... Biotechniques 70 (1), 37-48, 2021 | 7 | 2021 |
Effect of CRISPR knockout of AXIN1 or ARID1A on proliferation and migration of porcine hepatocellular carcinoma L Elkhadragy, K Dasteh Goli, WM Totura, MJ Carlino, MR Regan, ... Frontiers in Oncology 12, 904031, 2022 | 4 | 2022 |
A radioactive in vitro ERK3 kinase assay L Elkhadragy, W Long Bio-protocol 9 (16), e3332-e3332, 2019 | 3 | 2019 |
The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer AL Carlson, J Carrazco-Carrillo, A Loder, L Elkhadragy, ... International Journal of Molecular Sciences 23 (22), 14012, 2022 | 2 | 2022 |
Regulation of the expression and activity of Extracellular signal-regulated kinase 3 (ERK3) L Elkhadragy Wright State University, 2017 | 1 | 2017 |
Role of the Atypical MAPK ERK3 in Cancer Growth and Progression L Elkhadragy, A Myers, W Long Cancers 16 (7), 1381, 2024 | | 2024 |
Abstract No. 244 Characterization of Intratumor Heterogeneity in a Porcine Hepatocellular Carcinoma Model V Vijayakumar, L Elkhadragy, L Schook, R Gaba, M El-Kebir, ... Journal of Vascular and Interventional Radiology 34 (3), S111, 2023 | | 2023 |
DEVELOPMENT OF MULTIFOCAL HEPATOCELLULAR CARCINOMA IN TRANSGENIC PIGS BY PORTAL VEIN AUTOLOGOUS CELL INJECTION L Elkhadragy, LR Jordan, LB Schook, RC Gaba, KM Schachtschneider HEPATOLOGY 76, S1431-S1432, 2022 | | 2022 |
Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model L Elkhadragy, RC Khabbaz, RN Muchiri, WM Totura, JP Samuelson, ... Journal of Vascular and Interventional Radiology 33 (10), 1213-1221. e5, 2022 | | 2022 |
DEVELOPMENT OF A PRECISION HEPATOCELLULAR CARCINOMA MODEL IN TRANSGENIC PIGS BY EX VIVO CRISPR EDITING L Elkhadragy, MJ Carlino, LR Jordan, LB Schook, RC Gaba, ... HEPATOLOGY 74, 684A-684A, 2021 | | 2021 |
Development of ARID1A-deficient hepatocellular carcinoma in transgenic pigs L Elkhadragy, WM Totura, KD Goli, LB Schook, RC Gaba, ... Cancer Research 80 (16_Supplement), 6137-6137, 2020 | | 2020 |